Epidemiology of giant cell arteritis and polymyalgia rheumatica

10.1056/NEJMra011913

10.1016/S0889-857X(05)70232-5

10.1097/01.md.0000180042.42156.d1

10.1097/00005792-200009000-00001

10.1097/00005792-200301000-00002

10.1053/sarh.2001.16650

Gonzalez‐Gay MA, 2000, The spectrum of conditions mimicking polymyalgia rheumatica in northwestern Spain, J Rheumatol, 27, 2179

10.1002/art.1780390719

10.7326/0003-4819-127-1-199707010-00005

Cantini F, 2001, Shoulder ultrasonography in the diagnosis of polymyalgia rheumatica: a case–control study, J Rheumatol, 28, 1049

Cantini F, 2005, Inflammatory changes of hip synovial structures in polymyalgia rheumatica, Clin Exp Rheumatol, 23, 462

10.1136/ard.2007.084723

Gonzalez‐Gay MA, 1998, Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica, J Rheumatol, 25, 1750

10.1016/j.semarthrit.2003.09.007

10.7326/0003-4819-121-7-199410010-00003

10.7326/0003-4819-139-6-200309160-00015

10.1002/1529-0131(199905)42:5<844::AID-ANR2>3.0.CO;2-M

10.1196/annals.1358.023

10.1016/j.clim.2005.02.009

10.1161/CIRCULATIONAHA.108.789172

10.1002/art.1780400105

10.1016/S1568-9972(03)00064-8

Gonzalez‐Gay MA, 2004, Interferon‐γ gene microsatellite polymorphisms in patients with biopsy‐proven giant cell arteritis and isolated polymyalgia rheumatica, Clin Exp Rheumatol, 22, S18

10.1097/00005792-199909000-00002

10.1097/00002281-200201000-00002

10.1053/berh.2002.0260

10.1016/S0248-8663(82)80003-9

10.1002/art.1780340313

10.7326/0003-4819-123-3-199508010-00006

10.1093/rheumatology/33.10.938

Gran JT, 1997, The incidence of polymyalgia rheumatica and temporal arteritis in the county of Aust Agder, south Norway: a prospective study 1987–94, J Rheumatol, 24, 1739

10.1097/md.0b013e31803d1764

10.1002/art.1780300308

10.1093/rheumatology/38.12.1208

Franzen P, 1992, Giant cell arteritis and polymyalgia rheumatica in a region of Finland: an epidemiologic, clinical and pathologic study, 1984–1988, J Rheumatol, 19, 273

Bas‐Lando M, 2007, The incidence of giant cell arteritis in Jerusalem over a 25‐year period: annual and seasonal fluctuations, Clin Exp Rheumatol, 25, S15

10.1136/ard.60.4.367

10.1002/art.1780370705

Haugeberg G, 2000, Temporal arteritis in Vest Agder County in southern Norway: incidence and clinical findings, J Rheumatol, 27, 2624

10.1002/art.1780310607

10.1002/art.20227

10.1002/art.1780261007

10.1016/S0950-3579(97)80043-X

10.1002/art.11195

Gonzalez‐Gay MA, 1997, Giant cell arteritis in Lugo, Spain: a more frequent disease with fewer classic features, J Rheumatol, 24, 2166

Elling P, 1996, Synchronous variations of the incidence of temporal arteritis and polymyalgia rheumatica in different regions of Denmark: association with epidemics of Mycoplasma pneumoniae infection, J Rheumatol, 23, 112

10.1093/rheumatology/34.3.261

10.1002/art.1780380311

Gonzalez‐Gay MA, 1999, The spectrum of polymyalgia rheumatica in northwestern Spain: incidence and analysis of variables associated with relapse in a 10 year study, J Rheumatol, 26, 1326

10.1002/1529-0131(199906)42:6<1255::AID-ANR23>3.0.CO;2-P

Duhaut P, 1999, Giant cell arteritis, polymyalgia rheumatica, and viral hypotheses: a multicenter, prospective case‐control study, J Rheumatol, 26, 361

10.1111/j.1365-2133.1965.tb14630.x

10.1177/003693307902400203

Llorca J, 2004, Lack of association between altitude and incidence of giant cell arteritis in northwest Spain, Clin Exp Rheumatol, 22, 270

10.1093/rheumatology/41.4.445

10.1002/art.517

10.1002/art.10580

10.1016/j.jcv.2004.05.003

10.1053/sarh.2002.50025

Dababneh A, 1998, Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II association, J Rheumatol, 25, 2140

10.1002/1529-0131(200008)43:8<1749::AID-ANR11>3.0.CO;2-K

10.1093/rheumatology/kel324

10.1186/ar293

Rueda B, 2005, A functional variant of vascular endothelial growth factor is associated with severe ischemic complications in giant cell arteritis, J Rheumatol, 32, 1737

Salvarani C, 2000, Intercellular adhesion molecule 1 gene polymorphisms in polymyalgia rheumatica/giant cell arteritis: association with disease risk and severity, J Rheumatol, 27, 1215

Amoli MM, 2002, Intercellular adhesion molecule‐1 gene polymorphisms in isolated polymyalgia rheumatica, J Rheumatol, 29, 502

10.1093/ije/18.4.836

10.1002/1529-0131(199811)41:11<1960::AID-ART10>3.0.CO;2-X

10.1097/01.md.0000145369.25558.b5

Gonzalez‐Gay M, 2005, The diagnosis and management of patients with giant cell arteritis, J Rheumatol, 32, 1186

Klein RG, 1976, Skip lesions in temporal arteritis, Mayo Clin Proc, 51, 504

10.1111/j.1532-5415.1999.tb07442.x

10.1136/ard.58.6.335

Taylor‐Gjevre R, 2005, Temporal artery biopsy for giant cell arteritis, J Rheumatol, 32, 1279

10.1136/ard.2005.042770

10.1016/S0025-6196(12)65593-1

Ponge T, 1988, The efficacy of selective unilateral temporal artery biopsy versus bilateral biopsies for diagnosis of giant cell arteritis, J Rheumatol, 15, 997

Gonzalez‐Gay MA, 1992, Temporal arteritis in a northwestern area of Spain: study of 57 biopsy proven patients, J Rheumatol, 19, 277

10.7326/0003-4819-120-12-199406150-00003

10.1002/art.20231

10.1016/S0002-9343(97)00117-4

10.1002/art.11353

10.1097/01.md.0000145366.40805.f8

Gonzalez‐Juanatey C, 2006, Steroid therapy improves endothelial function in patients with biopsy‐proven giant cell arteritis, J Rheumatol, 33, 74

10.1016/j.semarthrit.2008.01.012

10.1002/art.23114

10.1002/art.22548

Uddhammar A, 2002, Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden, J Rheumatol, 29, 737

10.1016/S0002-9343(97)89458-2

Gonzalez‐Gay MA, 1997, Giant cell arteritis in Lugo, Spain, is associated with low longterm mortality, J Rheumatol, 24, 2171

10.1093/rheumatology/40.11.1238

Doran MF, 2002, Trends in the incidence of polymyalgia rheumatica over a 30 year period in Olmsted County, Minnesota, USA, J Rheumatol, 29, 1694